-
Technology/Science
[JW R&D] Installed ‘No. 1’ Blood Irradiator SANGRAY in Korea
2021-02-11 -
Technology/Science
[JW R&D] JW Leading the Dream of Completely Conquering Atopic Dermatitis
2021-03-09 -
Technology/Science
[JW R&D] JW starts up developing ‘innovative infusion solution plant facility’ jointly with public a
2021-03-09 -
Technology/Science
[JW R&D] JW, ‘Receiving Attention’ as a Leader of Innovative New Drugs (First-in-Class)
2021-03-09 -
Technology/Science
[JW R&D] Renal Anemia Treatment of JW Pharmaceutical, Achieved New Drug Approval in Japan
2021-03-09 -
Technology/Science
[JW R&D]JW, Making a New History of Developing Innovative New Drugs (first-in-class) in Korea
2021-03-09 -
Technology/Science
[JW R&D] JW, Installs an Innovative STAT3 Target Anticancer Drug Pipeline
2021-03-09 - More
Popular posts
Plan Story
PR
-
JW Pharmaceutical to Present Preclinical Results for Rare Pediatric Brain Disease Drug Candidate at World Orphan Drug Congress USA
-
JW Pharmaceutical Completes Last Patient Dosing in Phase 3 Clinical Trial for Gout Treatment 'Epaminurad'
-
JW Pharmaceutical Signs Exclusive In-Licensing Agreement with Gan & Lee for 'Bi-Weekly' GLP-1 Obesity Drug
-
JW Pharmaceutical Receives Phase 1 IND Approval for Hair Loss Treatment Candidate 'JW0061'
-
JW Pharmaceutical Secures U.S. Patent for First-in-Class Hair Loss Treatment Candidate 'JW0061'
-
JW Pharmaceutical’s AI-Driven Innovative Metabolic Disease Drug Candidate Selected for National Drug Development Project
R&D
JW of the day
